Cardiorenal anemia syndrome in chronic heart failure contributes to increased sympathetic nerve activity

Area of Science:

• Cardiology
• Nephrology
• Neuroscience

Background:

• Cardiorenal anemia syndrome (CRAS) is a complex condition affecting patients with chronic heart failure (CHF).
• The interplay between anemia, kidney dysfunction, and heart failure in CRAS and its impact on the nervous system remains incompletely understood.
• Sympathetic nervous system overactivity is a known contributor to the progression of CHF.

Purpose of the Study:

• To investigate whether CRAS in CHF patients contributes to sympathetic overactivity.
• To determine the role of sympathetic reflexes, specifically peripheral chemoreflex and baroreflex function, in mediating sympathetic overactivity in CRAS patients.
• To compare sympathetic nerve activity and reflex function between CHF patients with and without CRAS.

Main Methods:

• Prospective study comparing 15 patients with CRAS and CHF to 15 matched control CHF patients.
• Measurement of muscle sympathetic nerve activity (MSNA) and assessment of sympathetic baroreflex function.
• Evaluation of the effect of peripheral chemoreflex deactivation (100% oxygen breathing) on MSNA and baroreflex function.

Main Results:

• Baseline MSNA was significantly elevated in CHF patients with CRAS compared to controls.
• Sympathetic baroreflex function was significantly impaired in CHF patients with CRAS.
• Deactivation of peripheral chemoreflexes in CRAS patients led to a significant decrease in MSNA and improved sympathetic baroreflex function.
• Control CHF patients showed no significant changes in MSNA or baroreflex function with oxygen administration.

Conclusions:

• CRAS in CHF patients is associated with elevated sympathetic activity.
• This sympathetic overactivity is mediated by tonic activation of the peripheral chemoreflex.
• Impaired baroreflex function also contributes to the sympathetic dysregulation observed in CRAS patients.